In addition, symptomatic lesions can also be managed by hormonal modification including oral contraceptives, GnRH agonist such as Lupron, and estrogen antagonist such as tamoxifen, particularly if cytology reveal that the tumor is positive for the estrogen receptors [8-10]. Here, ESR1 is linked to neoplasm.